Supervisory board

  1. Supervisory Board

Prof. Joachim Schindler, PhD

Chairman of the Supervisory Board

After studying Business Administration (including a PhD), Joachim worked with accounting firms, and has been with KPMG since 1989. He is a Chartered Accountant and a Tax Adviser. Joachim’s primary experience is in assisting medium size to very large clients in ...

... Audit, Tax and Advisory. For more than 20 years, his focus has been on multinational companies and how to service them in the best possible way.

Joachim has held a number of key leadership positions; in addition to serving as Head of Audit and a Member of the Managing Board for KPMG Germany from 2004 to 2012, he was Head of Audit for the Europe, Middle East and Africa region from 2005 to 2010 and Global Head of Audit and a Member of the Global Executive Team from 2010 to 2013. He also serves on the board of a non-profit hospital group.

Joachim regularly lectures on accounting and auditing, and has published several articles in professional journals. He is an Honorary Professor at the Freie Universität, Berlin and currently serves as Vice-Chairman on the board of the IDW, the German Institute of Chartered Accountants.

Christoph Ehlers, LLM

Member of the Supervisory Board

Christoph is a German lawyer who obtained his degrees from the University of Konstanz, Germany, and the University of San Diego, USA. From 1983 to 1997, he held various investment and management positions at Commerzbank AG, Germany’s second largest private bank.

In 1997, Christoph started his own businesses working as a business angel developing technology driven companies, particularly in the Life Science sector. Under his leadership, numerous German companies has thrived to success. Apart from his involvement in the technological sector, Christoph is owner of Equicore Beteiligungs GmbH and founder and substantial shareholder of the Freiburger Vermögensmanagement GmbH (one of the leading private German portfolio management companies). He is also the co-founder and board member of one of the leading German economic and political think tanks, the "Stiftung Ordnungspolitik – Centrum für Europäische Politik", located in Freiburg. In addition, he is a member of various consulting boards.

Christoph has been one of the major and initial shareholders of CENTOGENE since 2008. In the initial years, he served the company as Managing Director. In 2014, Christoph became a member of CENTOGENE’s Supervisory Board focusing on the strategic orientation and development of the company.

Prof. Mathias Freund, MD

Member of the Supervisory Board

Mathias was Chairman of the Department of Hematology and Oncology at Rostock University and has been Secretary and Treasurer of the German Society of Hematology and Oncology since 1996 and Chairman of the Tumor Center of Rostock.

Mathias graduated in medicine at the Eberhard-Karls-University in Tübingen, Germany in 1974, and obtained his physician's license, doctorate and his license as a specialist of Internal Medicine and Hematology/Oncology at the same institution. His research activities in Tübingen focused on disseminated intravascular coagulation and shock lung, breast cancer, leukemias and non-Hodgkin's lymphomas. In 1982, he moved to the Department of Hematology and Oncology at Hannover Medical School. His clinical activities concentrated on high-grade and low-grade malignant non-Hodgkin's lymphomas, as well as chronic and acute leukemias. Besides chemotherapeutic approaches, he also developed a special interest in the basic and clinical effects of cytokines. Mathias subsequently chaired the Laboratory of Experimental Hematology. His activities focused on cell biologic aspects of growth and differentiation of acute and chronic leukemias as well as stem cell biology. Clinical and basic developments were documented in a series of International Symposia on Cytokines in Hematology, Oncology and Immunology in Hannover in 1989, 1991, and 1993. Mathias was secretary of the annual meeting of the German Society of Hematology and Oncology in Hannover 1989. In 1989, he received the ESMO European Certificate in Medical Oncology. In October 1994, he was appointed as chairman of the Department of Hematology and Oncology at Rostock University. His research concentrates on high-dose chemotherapy of hematopoietic neoplasias and solid tumors, bone marrow and blood stem cell transplantation and chronic GvHD.

Recently, the department has been involved in stem cell therapy for myocardial and vascular regeneration. Mathias has been licensed as a specialist in Hemostaseology and in Palliative Medicine since 2008.

Besides, Mathias was President of the Annual Meeting of the German, Austrian and Swiss Societies of Hematology and Oncology in 2005. Also, since 1996 he has been President of the Cancer Society of Mecklenburg-Vorpommern.

Mathias has an extensive track record in medical and scientific publications.

Holger Friedrich

Member of the Supervisory Board

Holger has more than 25 years of experience in the IT industry. His focus is on software engineering and IT architecture management. Holger holds several leadership positions in leading institutions, including partner of a global management consulting firm and as an ...

... executive board member in several technology firms. He served as chairman of SPM Technolgies (acquired by SAP), was Partner at McKinsey and Board member at Software AG. Besides that, Holger was executive board member of CORE, a think tank for technologies in the financial services industry.

Jacob Kaluski, M.Sc. in Pharmacy

Member of the Supervisory Board

Jacob has more than 30 years of experience gained working in the pharmaceutical industry, focusing on international marketing and drug development/clinical trials. He has held several leadership positions within a leading pharmaceutical and ...

biotechnology company, including Vice President and Business Manager for growth hormone.

Jacob served in numerous other high-level positions at prominent pharmaceutical companies and was co-founder of TKT-Europe-5S, which launched the first orphan drug in Europe.

Michael Schlenk, MBA

Member of the Supervisory Board

Michael earned a Diplom-Kaufmann degree from University Hamburg, Germany, and an MBA from University Bradford Management Centre, UK. Michael initially worked for 6 years as a management consultant in the area of technology transfer, and ...

... then for more than 20 years in the Life Science industry.

During his international career, Michael has lived and worked in more than 10 countries, holding positions as strategic consultant, marketing manager, area manager, general manager and president of subsidiaries of Novartis and Abbott.

Before joining CENTOGENE, Michael was CEO of Berlin based Biotechnology company for 7 years. He led the company to sustained profitability and prepared it for the trade sale. Under his leadership, the organization achieved numerous awards for fast growth and technological excellence: Deloitte Fast Forward Award (2 times), Step Award (FAZ German newspaper), BMBF and Peta. In 2010, the company was sold successfully to a leading Egyptian Pharma company.

Since 2003, Michael has been developing and investing as a business angel in young IT and Life Science companies and is a member of various supervisory boards. In January 2011, Michael became a CENTOGENE shareholder and was designated Chief Executive Officer (CEO).